Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 2 , Pages 148-152 , February 2010

Evaluation of direct method of drug susceptibility testing of Mycobacterium tuberculosis to rifampicin and isoniazid by nitrate reductase assay in a national reference laboratory

  • Potharaju Visalakshi

      Affiliations

    • Department of Microbiology, LRS Institute of TB and Respiratory Diseases, Sri Aurobindo Marg, New Delhi 110030, India
    • Corresponding Author InformationCorresponding author. Tel.: +91-11-26854929x207; fax: +91-11-26568227, +91-9811068236 (Mobile).
  • ,
  • Sandeep Kumar Meharwal

      Affiliations

    • Department of Microbiology, Saba University School Of Medicine, Saba Island, Netherlands Antilles
  • ,
  • Vittal Prasad Myneedu

      Affiliations

    • Department of Microbiology, LRS Institute of TB and Respiratory Diseases, Sri Aurobindo Marg, New Delhi 110030, India
  • ,
  • Degember Behera

      Affiliations

    • Department of Microbiology, LRS Institute of TB and Respiratory Diseases, Sri Aurobindo Marg, New Delhi 110030, India

Received 8 January 2009 ,Accepted 2 September 2009.

References 

  1. Affolabi D, Martin A, Palomino JC, Anagonou S, Portaels F. Evaluation of direct detection of Mycobacterium tuberculosis rifampicin resistance by nitrate reductase assay applied to sputum samples in Cotonou, Benin. J. Clin. Microbiol. 2007;45:2123–2125
  2. Altman DG. Practical statistics for medical research. In:  Altman DG editors. Interater agreement. London, United Kingdom: Chapman and Hall/cRC; 1999;p. 403–409
  3. Angeby KA, Klintz L, Hoffner SE. Rapid and expensive drug susceptibility testing of Mycobacterium tuberculosis with a Nitrate reductase assay. J. Clin. Microbiol. 2002;40:1553–1555
  4. Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Maher HT, et al. Mycobacteria: laboratory methods for testing drug sensitivity & resistance. Bull. W.H.O. 1963;29:565–578
  5. Caviedes L, Delgado J, Gilman RH. Tetrazolium microplate assay as rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of M. tuberculosis. J. Clin. Microbiol. 2002;40:1873–1874
  6. Center for Disease Control and Prevention . TB elimination cooperative agreement. Atlanta: Centers for Disease Control and Prevention; 2002;
  7. Coban AY, Birinci A, Ekinci B, Durupinar B. Drug susceptibility testing of Mycobacterium tuberculosis with Nitrate reductase assay. Int. J. Antimicrob. Agents. 2004;24:304–306
  8. Deeks JJ. Systematic review of evaluation of diagnostic and screening tests. BMJ. 2001;323:157–162
  9. Golyshevskaia VI, Korneev AA, Chernousova LN, Selina LG, Kazaroova TA, Grishina TD, et al. New microbiological techniques in diagnosis. Probl. Tuberk. 1996;6:22–25
  10. Golyshevskaia VI, Irtuganova OA, Smirnova NS, Domotenko LV. Comparison of nitrate reductase and automatic BACTEC MGIT 960 AST techniques for determining the drug sensitivity of Mycobacterium tuberculosis. Probl. Tuberk. Bolezn. Legk. 2003;8:34–37
  11. Inderlied CB, Salfinger M. Antimycobacterial agents and susceptibility test. In:  Murray PR,  Baron EJ,  Pfaller MA,  Tenover FC,  Yolken RH editor. Manual of clinical microbiology. 7th ed.. Washington, DC: American Society for Microbiology; 1999;p. 1601–1623
  12. Jaeschke R, Guyatt GH, Sackett DL, et al. Users guide to the medical literature. 111. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients. JAMA. 1994;271:703–707
  13. Kent PT, Kubica GP. In: Public health mycobacteriology. A guide for the level 111 laboratory. Atlanta, GA: U.S. Department of Health and Human Services. CDC; 1985;p. 96–103
  14. Lemus D, Martina A, Montoro E, Portaels F, Palmino JC. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 2004;54:130–133
  15. Musa RH, Ambroggi M, Souto A, Angeby KA. Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples. J. Clin. Microbiol. 2005;43:3159–3161
  16. Pan American Health Organization (PAHO) . Manual de bactetrilogia de la TBC: techincas y procedimientos basicos. Washington, DC: OPS; 1973;
  17. Panaiotov S, Kantardjiev T. Nitrate reductase assay for drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 2002;40:3881–3882
  18. Rossan R, Traore H, De Deenhouver H, Mijs W, Jannes G, De Rijk P, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization- assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother. 1997;41:2093–2098
  19. Sethi S, Sharma S, Sharma SK, Meharwal SK, Jindal SK, Sharma M. Drug susceptibility of Mycobacterium tuberculosis to primary antituberculosis drugs by nitrate reductase assay. Indian J. Med. Res. 2004;120:468–471
  20. Syre H, Phyu S, Sandvan P, Bjorvatn B, Grewal HM. Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid & rifampicin in liquid cultures. J. Clin. Microbiol. 2003;41:5173–5177
  21. World Health Organisation . Laboratory services in tuberculosis control. Culture. Part 111. Geneva, Switzerland: W.H.O.; 1998;WHO/TB/98.258
  22. World Health Organization . The W.H.O./IUATLD global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistant in the world, report no. 2: prevalence and trends. Geneva, Switzerland: World Health Organization; 2000;

PII: S0732-8893(09)00371-X

doi: 10.1016/j.diagmicrobio.2009.09.008

Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 2 , Pages 148-152 , February 2010